L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation-Reference-Cited by-同舟云学术

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

Published:2013-06-18 Issue:15 Volume:105 Page:1142-1150
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Zeimet Alain G.,Reimer Daniel,Huszar Monica,Winterhoff Boris,Puistola Ulla,Abdel Azim Samira,Müller-Holzner Elisabeth,Ben-Arie Alon,van Kempen Léon C.,Petru Edgar,Jahn Stephan,Geels Yvette P.,Massuger Leon F.,Amant Frédéric,Polterauer Stephan,Lappi-Blanco Elisa,Bulten Johan,Meuter Alexandra,Tanouye Staci,Oppelt Peter,Stroh-Weigert Monika,Reinthaller Alexander,Mariani Andrea,Hackl Werner,Netzer Michael,Schirmer Uwe,Vergote Ignace,Altevogt Peter,Marth Christian,Fogel Mina

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/105/15/1142/17312440/djt144.pdf

Reference44 articles.

1. Endometrial cancer state of the science meeting;Kitchener;Int J Gynecol Cancer,2009

2. Two pathogenetic types of endometrial carcinoma;Bokhman;Gynecol Oncol,1983

3. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management;Fader;Curr Opin Obstet Gynecol,2010

4. Pathology of endometrial carcinoma;Young,2004

5. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features;Sherman;Am J Surg Pathol,1992

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup;Gynecologic Oncology;2024-10

2. Asparaginase-like protein 1 as a prognostic tissue biomarker in clinicopathologically and molecularly characterized endometrial cancer;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. The game-changing impact of POLE mutations in oncology—a review from a gynecologic oncology perspective;Frontiers in Oncology;2024-08-22

4. An uncommon case of POLE mutated uterine carcinosarcoma − complemented by a review of literature;Gynecologic Oncology Reports;2024-08

5. How Can “No Specific Molecular Profile” Heterogeneity be Reduced in Molecularly Classified Endometrial Cancer?: Prognostic Significance of L1 Cell Adhesion Molecule;International Journal of Gynecological Pathology;2024-07-29